Explore China's 2024 TMT sector developments, from AI governance to online sales and industrial transformation. Discover key ...
Credit: Pormezz/Shutterstock. China’s National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application (NDA) for Stapokibart to treat seasonal ...
Harnessing Artificial Intelligence for Global Health Advancement. Journal of Data Analysis and Information Processing, 13, 66 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback